Teladoc is a star healthcare stock that has lost its shine. It was a hot item in the thick of the coronavirus pandemic, as telehealth solutions became a viable option in a world of shut-ins and office closures. Recent quarterly earnings disappointments compound the feeling among certain investors that the company's best days are behind it.